SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-4 - Registration of securities, business combinations:
SEC Accession No. 0001193125-03-094336
Filing Date
2003-12-15
Accepted
2003-12-15 16:36:47
Documents
14

Document Format Files

Seq Description Document Type Size
1 FORM S-4 ds4.htm S-4 2901546
3 FORM OF GENOME VOTING AGREEMENT dex91.htm EX-9.1 45881
4 SECURITY AGREEMENT dex101.htm EX-10.1 19742
5 WARRANT TO PURCHASE dex102.htm EX-10.2 52771
6 NOTE AMENDMENT AND EXCHANGE AGREEMENT dex103.htm EX-10.3 263977
7 REGISTRATION RIGHTS AGREEMENT dex104.htm EX-10.4 145683
8 PROMISSORY NOTE dex105.htm EX-10.5 22432
9 CONSENT OF ERNST & YOUNG dex231.htm EX-23.1 1744
10 CONSET OF ERNST & YOUNG LLP dex232.htm EX-23.2 1629
11 CONSENT OF ROPES & GRAY LLP dex233.htm EX-23.3 2128
12 CONSENT OF GUNDERSON DETTMER STOUGH VILLENEUVE FRANKLIN & HACHIGIAN LLP dex234.htm EX-23.4 2643
13 CONSENT OF HARRIS NESBITT CORP. dex235.htm EX-23.5 3958
14 CONSENT OF MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED dex994.htm EX-99.4 3112
15 GRAPHIC g47686g34n55.jpg GRAPHIC 40678
  Complete submission text file 0001193125-03-094336.txt   3511142
Mailing Address 100 BEAVER STREET WALTHAM MA 02453
Business Address 1OO BEAVER ST WALTHAM MA 02453 7813982300
GENOME THERAPEUTICS CORP (Filer) CIK: 0000356830 (see all company filings)

IRS No.: 042297484 | State of Incorp.: MA | Fiscal Year End: 0831
Type: S-4 | Act: 33 | File No.: 333-111171 | Film No.: 031054982
SIC: 2835 In Vitro & In Vivo Diagnostic Substances